Lanean...
Erythropoietin increases macrophage-mediated T cell suppression
Erythropoietin (EPO), used to treat anemia in cancer patients, has been reported to accelerate tumor progression and increase mortality. Research of the mechanism for this effect has focused upon EPOR expression by tumor cells. We model the high macrophage to lymphocyte ratio found in tumor microenv...
Gorde:
| Argitaratua izan da: | Cell Immunol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4983461/ https://ncbi.nlm.nih.gov/pubmed/27262376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2016.05.004 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|